Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
2
25%
Ph phase_2
5
63%

Phase Distribution

2

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
5(62.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Active, not recruiting1
Withdrawn1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (25.0%)
Phase 25 (62.5%)
N/A1 (12.5%)

Trials by Status

active_not_recruiting113%
withdrawn113%
completed450%
enrolling_by_invitation113%
unknown113%

Recent Activity

1 active trials
Showing 5 of 8
enrolling_by_invitationnot_applicable

Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT07539662
active_not_recruitingphase_2

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

NCT04761770
withdrawnphase_2

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

NCT04395092
completedphase_2

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

NCT02876679
completedphase_1

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

NCT01379209
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07539662Not Applicable

Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Enrolling By Invitation
NCT04761770Phase 2

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Active Not Recruiting
NCT04395092Phase 2

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Withdrawn
NCT02876679Phase 2

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Completed
NCT01379209Phase 1

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Completed
NCT00063817Phase 1

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Completed
NCT00189488Phase 2

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Completed
NCT01238328Phase 2

Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis

Unknown

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8